These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 25223974)
21. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase. Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390 [TBL] [Abstract][Full Text] [Related]
22. Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe. Pozo F; Lina B; Andrade HR; Enouf V; Kossyvakis A; Broberg E; Daniels R; Lackenby A; Meijer A; J Clin Virol; 2013 May; 57(1):5-12. PubMed ID: 23375738 [TBL] [Abstract][Full Text] [Related]
23. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure. Fischer PB; Karlsson GB; Dwek RA; Platt FM J Virol; 1996 Oct; 70(10):7153-60. PubMed ID: 8794362 [TBL] [Abstract][Full Text] [Related]
24. Detection of nonhemagglutinating influenza a(h3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus culture. van Baalen CA; Els C; Sprong L; van Beek R; van der Vries E; Osterhaus AD; Rimmelzwaan GF J Clin Microbiol; 2014 May; 52(5):1672-7. PubMed ID: 24622097 [TBL] [Abstract][Full Text] [Related]
25. Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance. McKimm-Breschkin JL Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):25-36. PubMed ID: 23279894 [TBL] [Abstract][Full Text] [Related]
26. In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate. Ilyushina NA; Donnelly RP Antiviral Res; 2014 Nov; 111():112-20. PubMed ID: 25245230 [TBL] [Abstract][Full Text] [Related]
27. In vitro inhibition of human influenza A virus replication by chloroquine. Ooi EE; Chew JS; Loh JP; Chua RC Virol J; 2006 May; 3():39. PubMed ID: 16729896 [TBL] [Abstract][Full Text] [Related]
28. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Sheu TG; Deyde VM; Okomo-Adhiambo M; Garten RJ; Xu X; Bright RA; Butler EN; Wallis TR; Klimov AI; Gubareva LV Antimicrob Agents Chemother; 2008 Sep; 52(9):3284-92. PubMed ID: 18625765 [TBL] [Abstract][Full Text] [Related]
29. The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding. Fischer PB; Collin M; Karlsson GB; James W; Butters TD; Davis SJ; Gordon S; Dwek RA; Platt FM J Virol; 1995 Sep; 69(9):5791-7. PubMed ID: 7543588 [TBL] [Abstract][Full Text] [Related]
30. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza. Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654 [TBL] [Abstract][Full Text] [Related]
31. Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model. Miller JL; Spiro SG; Dowall SD; Taylor I; Rule A; Alonzi DS; Sayce AC; Wright E; Bentley EM; Thom R; Hall G; Dwek RA; Hewson R; Zitzmann N PLoS One; 2016; 11(11):e0167018. PubMed ID: 27880800 [TBL] [Abstract][Full Text] [Related]
32. Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring. Little K; Leang SK; Butler J; Baas C; Harrower B; Mosse J; Barr IG; Hurt AC Euro Surveill; 2015; 20(45):. PubMed ID: 26608955 [TBL] [Abstract][Full Text] [Related]
33. In vivo therapeutic protection against influenza A (H1N1) oseltamivir-sensitive and resistant viruses by the iminosugar UV-4. Stavale EJ; Vu H; Sampath A; Ramstedt U; Warfield KL PLoS One; 2015; 10(3):e0121662. PubMed ID: 25786028 [TBL] [Abstract][Full Text] [Related]
34. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India. Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590 [TBL] [Abstract][Full Text] [Related]
35. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway. Yan H; Wang H; Ma L; Ma X; Yin J; Wu S; Huang H; Li Y Virol J; 2018 May; 15(1):88. PubMed ID: 29783993 [TBL] [Abstract][Full Text] [Related]
36. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season. Okomo-Adhiambo M; Sleeman K; Lysén C; Nguyen HT; Xu X; Li Y; Klimov AI; Gubareva LV Influenza Other Respir Viruses; 2013 Sep; 7(5):645-58. PubMed ID: 23575174 [TBL] [Abstract][Full Text] [Related]
37. A novel benzo-heterocyclic amine derivative N30 inhibits influenza virus replication by depression of Inosine-5'-Monophospate Dehydrogenase activity. Hu J; Ma L; Wang H; Yan H; Zhang D; Li Z; Jiang J; Li Y Virol J; 2017 Mar; 14(1):55. PubMed ID: 28298229 [TBL] [Abstract][Full Text] [Related]
39. Structure-Activity Studies of N-Butyl-1-deoxynojirimycin (NB-DNJ) Analogues: Discovery of Potent and Selective Aminocyclopentitol Inhibitors of GBA1 and GBA2. Gu X; Gupta V; Yang Y; Zhu JY; Carlson EJ; Kingsley C; Tash JS; Schönbrunn E; Hawkinson J; Georg GI ChemMedChem; 2017 Dec; 12(23):1977-1984. PubMed ID: 28975712 [TBL] [Abstract][Full Text] [Related]
40. Genetic characterisation of influenza A(H1N1)pdm09 viruses circulating in Assam, Northeast India during 2009-2015. Biswas D; Dutta M; Sarmah K; Yadav K; Buragohain M; Sarma K; Borkakoty B Indian J Med Microbiol; 2019; 37(1):42-49. PubMed ID: 31424009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]